Cellular adaptation during chronic neonatal hypoxic pulmonary hypertension.
Newborn animals develop more severe hypoxic pulmonary hypertension than do adults, their vascular changes are greater, and both the hypertension and vascular changes occur more rapidly. We hypothesize that this differential developmentally controlled response may arise from either a difference in the type or quantity of endogenously secreted mediators in response to a given injury or a difference in the replicative and/or matrix-producing response of the vascular cells to physical or chemical stimuli. We investigated the effect of chronic hypoxia (14 days) on the proliferative and matrix-producing phenotype of the neonatal (14-day-old) pulmonary artery smooth muscle cell (SMC) and examined the heterogeneity and potential mechanisms responsible for this response. In situ hybridization studies demonstrated a remarkable change in the distribution of cells hybridizing with a tropoelastin cRNA probe after 14 days of hypoxia. Studies also demonstrated a population of SMC that did not hybridize with the elastin or collagen probes, indicating that the pulmonary artery contains SMC of multiple phenotypes and that the response to hypoxic and hemodynamic stress is not uniform for the various types. Bromodeoxyuridine labeling experiments indicated a large increase in DNA synthesis in hypertensive vessels, which, again, was not uniform either across or along the arterial wall. In vitro experiments with neonatal SMC suggested that hypoxia alone could not be responsible for the proliferative or matrix changes.(ABSTRACT TRUNCATED AT 250 WORDS)
University of Colorado Health Sciences Center, Cardiovascular Pulmonary Research Laboratory, Denver.
K R
KR
Stenmark
A A
AA
Aldashev
E C
EC
Orton
A G
AG
Durmowicz
D B
DB
Badesch
W C
WC
Parks
R P
RP
Mecham
N F
NF
Voelkel
J T
JT
Reeves
D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001794:Blood Pressure; D002455:Cell Division; D002908:Chronic Disease; D016326:Extracellular Matrix Proteins / Q000096:biosynthesis; D006801:Humans; D006976:Hypertension, Pulmonary / Q000473:pathology / Q000503:physiopathology*; D000860:Hypoxia / Q000473:pathology / Q000503:physiopathology*; D010641:Phenotype; D011651:Pulmonary Artery / Q000473:pathology / Q000503:physiopathology*
D016326:Extracellular Matrix Proteins